Vimarsana
Biggest News Aggregation in the World

Page 2 - Chained Equations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chained Equations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chained Equations Today - Breaking & Trending Today

Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC–WHO clinical characterisation protocol - Vimarsana News

Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC–WHO clinical characterisation protocol

Marina Wainstein and colleagues examine acute kidney injury (AKI) incidence, severity, and outcomes among patients with COVID-19 using both a traditional and extended definition of AKI.

Source: plos.org
Reproductive factors and the risk of incident dementia: A cohort study of UK Biobank participants - Vimarsana News

Reproductive factors and the risk of incident dementia: A cohort study of UK Biobank participants

In a cohort study, Jessica Gong and colleagues investigate associations between reproductive factors, number of children, and dementia among individuals in the UK Biobank.

Source: plos.org
Epidemiology of type 2 diabetes remission in Scotland in 2019: A cross-sectional population-based study - Vimarsana News

Epidemiology of type 2 diabetes remission in Scotland in 2019: A cross-sectional population-based study

Mireille Captieux and co-workers report on population-level evidence for remission of type 2 diabetes in Scotland.

Source: plos.org
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19 - Vimarsana News

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

Abstract While it is now widely accepted that host inflammatory responses contribute to lung injury, the pathways that drive severity and distinguish coronavirus disease 2019 (COVID-19) from other viral lung diseases remain poorly characterized. We analyzed plasma samples from 471 hospitalized patients recruited through the prospective multicenter ISARIC4C study and 39 outpatients with mild disease, enabling extensive characterization of responses across a full spectrum of COVID-19 severity. Progressive elevation of levels of numerous inflammatory cytokines and chemokines (including IL-6, CXC...